Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Esophageal Cancer Market to Grow from $1.65 Billion in 2026 to $2.37 Billion by 2030: Pfizer, Roche, Merck & Co. Dominate

globenewswire.com
PFE Pfizer is mentioned as a major company pioneering advances in the esophageal cancer market, which is projected to grow significantly. The article does not provide specific details on Pfizer's performance or future outlook within this market. MRK Merck & Co. is identified as a key player in the esophageal cancer market, which is forecast to grow. The article mentions their involvement in pioneering advances but lacks specific details on their market share or future prospects. NVS Novartis AG is named as one of the major companies participating in the esophageal cancer market, which is projected for significant growth. The article does not provide specific information regarding Novartis's contributions or market standing. PRPH ProPhase Labs, Inc. is highlighted for acquiring rights to a pre-cancer diagnostic screening test, aiming to support early interventions and potentially save lives. This strategic move positions the company positively within the growing esophageal cancer market.

Esophageal Cancer Market to Grow from $1.65 Billion in 2026 to $2.37 Billion by 2030: Pfizer, Roche, Merck & Co. Dominate Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Esophageal Cancer Market Report 2026" has been added to ResearchAndMarkets.com's offering.

The global esophageal cancer market is poised for substantial growth, evolving from $1.51 billion in 2025 to an anticipated $1.65 billion by 2026, reflecting a compound annual growth rate (CAGR) of 9.1%. This growth trend is driven by factors such as increased consumption of tobacco and alcohol, the prevalence of late-stage diagnoses, chemotherapy reliance, expanding hospital oncology facilities, and an aging population. Forecasts indicate the market will reach $2.37 billion by 2030, with a CAGR of 9.5%. This surge is attributable to advancements in precision oncology, the development of immunotherapies, early screening programs, enhanced imaging technologies, and a growing emphasis on personalized cancer care.

Emerging market trends include the rising adoption of targeted cancer therapies, combination treatment methodologies, advancements in managing advanced-stage cancer, growth in minimally invasive surgical procedures, and a heightened focus on early detection and diagnosis. The increase in esophageal cancer incidence is a key driver for the market, necessitating a greater demand for diagnostic procedures like endoscopy and imaging tests. The American Cancer Society highlighted 16,120 new deaths from esophageal cancer in 2023, with a slight increase projected for 2024. This rising incidence is set to further propel market growth.

Leading companies in the esophageal cancer market are dedicating efforts to product innovation, particularly in precision medicine, which offers personalized cancer management strategies. In March 2023, Previse launched Esopredict, a precision medicine solution that assists in effectively managing esophageal cancer risk through accurate five-year risk predictions based on Barrett's esophagus cells. Such innovations address crucial unmet medical needs, empowering healthcare providers to identify and manage patients at elevated risk of developing esophageal cancer.

Furthering these efforts, ProPhase Labs, Inc. acquired rights for the BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test from Stella Diagnostics, Inc. This acquisition aims to support early interventions, potentially saving lives through preemptive treatments, such as ablation procedures. The global esophageal cancer market sees substantial participation from major companies, including Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, and others, who are pioneering advances in this field.

In 2025, North America emerged as the dominant region within the esophageal cancer market, with Asia Pacific anticipated to be the fastest-growing region moving forward. The regions encompassed in the market analysis span Asia-Pacific, South East Asia, Western and Eastern Europe, North America, South America, Middle East, and Africa. However, tariffs are impeding market growth by inflating costs for imported oncology drugs and diagnostic systems, impacting treatment budgets for hospitals and specialty centers in developed areas. This situation nevertheless fosters regional pharmaceutical manufacturing by encouraging domestic production of oncology drugs.

Report Scope

The report provides answers to critical questions about the market's largest and fastest-growing segments, its relation to the wider economy, and the forces shaping its future, including technological advancements, regulatory shifts, and changing consumer preferences.

This comprehensive report covers market characteristics, size, growth, segmentation, regional and country breakdowns, total addressable market, market attractiveness scores, competitive landscape, market shares, and strategic trends. It profiles historical and forecasted market growth by geography.

Markets Covered:

1) By Type: Esophageal Squamous-Cell Carcinoma; Esophageal Adenocarcinoma; Other Types

2) By Treatment Type: Chemotherapy; Targeted Therapy; Other Treatment Types

3) By Route Of Administration: Oral; Parenteral; Other Routes

4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy

5) By End Users: Hospitals; Homecare; Specialty Centers; Other End Users

Geographies and Regions Covered: Countries include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, and Spain. Regional coverage extends across Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Data & Time Series: Encompasses five years of historic data and ten years of forecasts. Includes analysis of market size ratios, growth trends, GDP, and expenditure per capita.

Key Attributes

The companies featured in this Esophageal Cancer market report include:

For more information about this report visit https://www.researchandmarkets.com/r/hs0fia

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment